Modeling loop backbone flexibility in receptor‐ligand docking simulations
暂无分享,去创建一个
[1] Martin Zacharias,et al. Efficient inclusion of receptor flexibility in grid‐based protein–ligand docking* , 2011, J. Comput. Chem..
[2] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[3] Michel F Sanner,et al. FLIPDock: Docking flexible ligands into flexible receptors , 2007, Proteins.
[4] Jeffrey Skolnick,et al. Assessment of programs for ligand binding affinity prediction , 2008, J. Comput. Chem..
[5] Egon L. Willighagen,et al. The Blue Obelisk—Interoperability in Chemical Informatics , 2006, J. Chem. Inf. Model..
[6] B. X. Carlson,et al. A single glycine residue at the entrance to the first membrane-spanning domain of the gamma-aminobutyric acid type A receptor beta(2) subunit affects allosteric sensitivity to GABA and anesthetics. , 2000, Molecular pharmacology.
[7] Hongyi Zhou,et al. What is a desirable statistical energy functions for proteins and how can it be obtained? , 2007, Cell Biochemistry and Biophysics.
[8] Richard A Friesner,et al. Prediction of Protein Loop Conformations using the AGBNP Implicit Solvent Model and Torsion Angle Sampling. , 2008, Journal of chemical theory and computation.
[9] W. Wenzel,et al. Comparison of stochastic optimization methods for receptor-ligand docking , 2002 .
[10] Rafael Najmanovich,et al. Side‐chain flexibility in proteins upon ligand binding , 2000, Proteins.
[11] N. Go,et al. Ring Closure and Local Conformational Deformations of Chain Molecules , 1970 .
[12] Christopher W Murray,et al. Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation. , 2005, Journal of medicinal chemistry.
[13] J. Sebolt-Leopold,et al. Targeting the mitogen-activated protein kinase cascade to treat cancer , 2004, Nature Reviews Cancer.
[14] D. Faulds,et al. Etanercept: a review of its use in rheumatoid arthritis. , 1999, Drugs.
[15] R. Davis,et al. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.
[16] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[17] J. Zheng,et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. , 1991, Science.
[18] Bert L. de Groot,et al. Conformational Transitions upon Ligand Binding: Holo-Structure Prediction from Apo Conformations , 2010, PLoS Comput. Biol..
[19] Nathan A. Baker,et al. Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] Ruben Abagyan,et al. A new method for ligand docking to flexible receptors by dual alanine scanning and refinement (SCARE) , 2008, J. Comput. Aided Mol. Des..
[21] Horst Kessler,et al. Multiple N-methylation by a designed approach enhances receptor selectivity. , 2007, Journal of medicinal chemistry.
[22] Christopher W. Murray,et al. The sensitivity of the results of molecular docking to induced fit effects: Application to thrombin, thermolysin and neuraminidase , 1999, J. Comput. Aided Mol. Des..
[23] Johan Åqvist,et al. Ligand binding affinity prediction by linear interaction energy methods , 1998, J. Comput. Aided Mol. Des..
[24] Spencer S Ericksen,et al. Three amino acids in the D2 dopamine receptor regulate selective ligand function and affinity , 2009, Journal of neurochemistry.
[25] Dan S. Tawfik,et al. Structure and kinetics of a transient antibody binding intermediate reveal a kinetic discrimination mechanism in antigen recognition. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[26] Bethan Hughes,et al. 2009 FDA drug approvals , 2010, Nature Reviews Drug Discovery.
[27] R. Nussinov,et al. How different are structurally flexible and rigid binding sites? Sequence and structural features discriminating proteins that do and do not undergo conformational change upon ligand binding. , 2007, Journal of molecular biology.
[28] L Bibbs,et al. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.
[29] Themis Lazaridis,et al. Contributions to the binding free energy of ligands to avidin and streptavidin , 2002, Proteins.
[30] B Montgomery Pettitt,et al. Fast Calculations of Electrostatic Solvation Free Energy from Reconstructed Solvent Density using proximal Radial Distribution Functions. , 2011, The journal of physical chemistry letters.
[31] G. Klebe. Virtual ligand screening: strategies, perspectives and limitations , 2006, Drug Discovery Today.
[32] Guilherme Menegon Arantes,et al. Flexibility and inhibitor binding in cdc25 phosphatases , 2010, Proteins.
[33] P. Kollman,et al. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? , 2000 .
[34] S. Teague. Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.
[35] Wolfgang Wenzel,et al. Increasing Diversity in In-silico Screening with Target Flexibility , 2005, CompLife.
[36] R. Nussinov,et al. Induced Fit, Conformational Selection and Independent Dynamic Segments: an Extended View of Binding Events Opinion , 2022 .
[37] T. Weikl,et al. Selected‐fit versus induced‐fit protein binding: Kinetic differences and mutational analysis , 2008, Proteins.
[38] Wolfgang Wenzel,et al. Accuracy of binding mode prediction with a cascadic stochastic tunneling method , 2007, Proteins.
[39] J. Pouysségur,et al. Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs. , 2003, Progress in cell cycle research.
[40] Gisbert Schneider,et al. Structure-Based Virtual Screening of FGFR Inhibitors , 2012, BioDrugs.
[41] David Baker,et al. Protein-protein docking with backbone flexibility. , 2007, Journal of molecular biology.
[42] Martin Zacharias,et al. Syntheses and activities of backbone‐side chain cyclic octapeptide ligands with N‐functionalized phosphotyrosine for the N‐terminal SH2‐domain of the protein tyrosine phosphatase SHP‐1 , 2010, Journal of peptide science : an official publication of the European Peptide Society.
[43] Jeffrey J. Gray,et al. Conformer selection and induced fit in flexible backbone protein-protein docking using computational and NMR ensembles. , 2008, Journal of molecular biology.
[44] John Kuriyan,et al. A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain , 2006, PLoS biology.
[45] Ruben Abagyan,et al. Consistent Improvement of Cross-Docking Results Using Binding Site Ensembles Generated with Elastic Network Normal Modes , 2009, J. Chem. Inf. Model..
[46] Jyothi Subramanian,et al. Modeling and Selection of Flexible Proteins for Structure‐Based Drug Design: Backbone and Side Chain Movements in p38 MAPK , 2008, ChemMedChem.
[47] M. DePristo,et al. Relation between native ensembles and experimental structures of proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[48] R Abagyan,et al. Flexible protein–ligand docking by global energy optimization in internal coordinates , 1997, Proteins.
[49] Kai Zhu,et al. Toward better refinement of comparative models: Predicting loops in inexact environments , 2008, Proteins.
[50] Wolfgang Wenzel,et al. Flexible side chain models improve enrichment rates in in silico screening. , 2008, Journal of medicinal chemistry.
[51] N. Ben-Tal,et al. The ConSurf‐HSSP database: The mapping of evolutionary conservation among homologs onto PDB structures , 2004, Proteins.
[52] E. Jaeger,et al. Docking: successes and challenges. , 2005, Current pharmaceutical design.
[53] Barbara M. Bolten,et al. Trends in development cycles , 2002, Nature Reviews Drug Discovery.
[54] John C. Lee,et al. p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. , 2001, Progress in medicinal chemistry.
[55] W. Wenzel,et al. Stochastic Tunneling Approach for Global Minimization of Complex Potential Energy Landscapes , 1999 .
[56] Claudio N. Cavasotto,et al. Protein flexibility in ligand docking and virtual screening to protein kinases. , 2004, Journal of molecular biology.
[57] Aleksandr V. Smirnov,et al. Watching a Protein as it Functions with 150-ps Time-Resolved X-ray Crystallography , 2003, Science.
[58] Thomas M Frimurer,et al. Ligand-induced conformational changes: improved predictions of ligand binding conformations and affinities. , 2003, Biophysical journal.
[59] Markus Wagener,et al. A flexible approach to induced fit docking. , 2007, Journal of medicinal chemistry.
[60] T. Steinbrecher,et al. Towards accurate free energy calculations in ligand protein-binding studies. , 2010, Current medicinal chemistry.
[61] K. Dill,et al. Predicting absolute ligand binding free energies to a simple model site. , 2007, Journal of molecular biology.
[62] Wolfgang Wenzel,et al. Receptor flexibility in small‐molecule docking calculations , 2011 .
[63] R. Dror,et al. A conserved protonation-dependent switch controls drug binding in the Abl kinase , 2009, Proceedings of the National Academy of Sciences.
[64] J A McCammon,et al. Accommodating protein flexibility in computational drug design. , 2000, Molecular pharmacology.
[65] A. Leach,et al. Ligand docking to proteins with discrete side-chain flexibility. , 1994, Journal of molecular biology.
[66] Iris Antes,et al. DynaDock: A new molecular dynamics‐based algorithm for protein–peptide docking including receptor flexibility , 2010, Proteins.
[67] Roger S Armen,et al. An Evaluation of Explicit Receptor Flexibility in Molecular Docking Using Molecular Dynamics and Torsion Angle Molecular Dynamics. , 2009, Journal of chemical theory and computation.
[68] György M. Keserü,et al. Ensemble Docking into Flexible Active Sites. Critical Evaluation of FlexE against JNK-3 and beta-Secretase , 2006, J. Chem. Inf. Model..
[69] Peter E Wright,et al. Millisecond timescale fluctuations in dihydrofolate reductase are exquisitely sensitive to the bound ligands , 2010, Proceedings of the National Academy of Sciences.
[70] A. Sali,et al. Protein Structure Prediction and Structural Genomics , 2001, Science.
[71] Taebo Sim,et al. A general strategy for creating "inactive-conformation" abl inhibitors. , 2006, Chemistry & biology.
[72] David S. Goodsell,et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .
[73] Christoph A. Sotriffer,et al. The Challenge of Affinity Prediction: Scoring Functions for Structure‐Based Virtual Screening , 2011 .
[74] M. Zacharias,et al. Protein-ligand docking accounting for receptor side chain and global flexibility in normal modes: evaluation on kinase inhibitor cross docking. , 2008, Journal of medicinal chemistry.
[75] Xiaoling Xie,et al. Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors. , 2007, Journal of medicinal chemistry.
[76] Dariusz Plewczynski,et al. Can we trust docking results? Evaluation of seven commonly used programs on PDBbind database , 2011, J. Comput. Chem..
[77] M L Teodoro,et al. Conformational flexibility models for the receptor in structure based drug design. , 2003, Current pharmaceutical design.
[78] Madhusudan,et al. Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit. , 2004, Biochemistry.
[79] Jens Meiler,et al. ROSETTALIGAND: Protein–small molecule docking with full side‐chain flexibility , 2006, Proteins.
[80] E. Coutsias,et al. Sub-angstrom accuracy in protein loop reconstruction by robotics-inspired conformational sampling , 2009, Nature Methods.
[81] W. C. Still,et al. Semianalytical treatment of solvation for molecular mechanics and dynamics , 1990 .
[82] Mark A. Wilson,et al. Intrinsic motions along an enzymatic reaction trajectory , 2007, Nature.
[83] Michael K. Gilson,et al. Enhanced docking with the mining minima optimizer: Acceleration and side‐chain flexibility , 2002, J. Comput. Chem..
[84] P. Kollman,et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.
[85] Djamal Bouzida,et al. Complexity and simplicity of ligand-macromolecule interactions: the energy landscape perspective. , 2002, Current opinion in structural biology.
[86] M. Lill. Efficient incorporation of protein flexibility and dynamics into molecular docking simulations. , 2011, Biochemistry.
[87] K. Smalley,et al. A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? , 2003, International journal of cancer.
[88] L. Johnson,et al. Protein Kinase Inhibitors: Insights into Drug Design from Structure , 2004, Science.
[89] Gerhard Klebe,et al. PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations , 2007, Nucleic Acids Res..
[90] J. An,et al. Structure-based virtual screening of chemical libraries for drug discovery. , 2006, Current opinion in chemical biology.
[91] T. Langer,et al. Charakterisierung der Dynamik der Kinase p38 in freiem und ligandgebundenem Zustand durch NMR‐Spektroskopie , 2006 .
[92] D. Koshland. Application of a Theory of Enzyme Specificity to Protein Synthesis. , 1958, Proceedings of the National Academy of Sciences of the United States of America.
[93] Christopher I. Bayly,et al. Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validation , 2002, J. Comput. Chem..
[94] R. Morphy. Selectively nonselective kinase inhibition: striking the right balance. , 2010, Journal of medicinal chemistry.
[95] R. Nussinov,et al. The role of dynamic conformational ensembles in biomolecular recognition. , 2009, Nature chemical biology.
[96] Markus A Lill,et al. Raptor: combining dual-shell representation, induced-fit simulation, and hydrophobicity scoring in receptor modeling: application toward the simulation of structurally diverse ligand sets. , 2004, Journal of medicinal chemistry.
[97] J. McCubrey,et al. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). , 2003, International journal of oncology.
[98] R M Stroud,et al. Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking. , 2001, Chemistry & biology.
[99] Harold A. Scheraga,et al. Standard‐geometry chains fitted to X‐ray derived structures: Validation of the rigid‐geometry approximation. II. Systematic searches for short loops in proteins: Applications to bovine pancreatic ribonuclease A and human lysozyme , 1992 .
[100] Jerry L. Adams,et al. 2,4,5- triarylimidazole inhibitors of IL-1 biosynthesis , 1995 .
[101] Ian W. Davis,et al. RosettaLigand docking with full ligand and receptor flexibility. , 2009, Journal of molecular biology.
[102] T. Oas,et al. Conformational selection or induced fit: A flux description of reaction mechanism , 2009, Proceedings of the National Academy of Sciences.
[103] N L Carteron,et al. Cytokines in rheumatoid arthritis: trials and tribulations. , 2000, Molecular medicine today.
[104] Somesh D. Sharma,et al. Managing protein flexibility in docking and its applications. , 2009, Drug discovery today.
[105] D. Strumberg,et al. The Ras-Raf-MEK-ERK Pathway in the Treatment of Cancer , 2002, Oncology Research and Treatment.
[106] Giulio Rastelli,et al. Fast and accurate predictions of binding free energies using MM‐PBSA and MM‐GBSA , 2009, J. Comput. Chem..